Epstein-Barr virus (EBV)-associated smooth-muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV-associated large- cell lymphomas: Case report

American Journal of Surgical Pathology

Volumn 20, Issue 12, 1996, Pages 1511-1519

  Kingma, D W ^a,d   Shad, A ^a   Tsokos, M ^a   Fest, T ^a   Otsuki, T ^a   Frekko, K ^a   Werner, E ^b,c   Werner, A ^b,c   Magrath, I ^a   Raffeld, M ^a   Jaffe, E S ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASE PAIRING; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; FIBROBLAST; HEART DILATATION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LARGE CELL LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MUSCLE TUMOR; VIRUS ONCOGENE;

ABDOMINAL NEOPLASMS; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; GENE REARRANGEMENT; HEART TRANSPLANTATION; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER NEOPLASMS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; NEOPLASMS, MUSCLE TISSUE; POLYMERASE CHAIN REACTION; SARCOMA, KAPOSI; TUMOR VIRUS INFECTIONS;

EID: 10544245675     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199612000-00011     Document Type: Article

References (33)

1. Beck JS, Kwitek AE, Cogen PH, Metzger AK, Duyk GM, Sheffeld VC. A denaturing gradient gel electrophoresis assay for sensitive detection of p53 mutations. Hum Genet 1993;91:25-30.
2. Cesarman E, Chang Y, Moore P, Said J, Knowles D. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332: 1186-91.
3. Chang Y, Cesarman E, Pessin M, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
4. Chen M, Tsai C, Liang C, et al. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992:2131.
5. Cleary ML, Sklar J. Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet 1984;2: 489-93.
6. d'Amore E, Manivel C, Gajl-Peczalska K, et al. B-cell lympho-proliferative disorders after bone marrow transplant: an analysis of 10 cases with emphasis on Epstein-Barr virus detection by in situ hybridization. Cancer 1991;68:1285-95.
7. Edwards R, Raab-Traub N. Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas. J Virol 1994;68(3):1309-15.
8. Finke J, Lange W, Mertelsmann R, Dolken G. Bcl-2 induction is part of the strategy of Epstein-Barr virus. Leuk Lymph 1994;12: 413-9.
9. Frank D, Cesarman E, Liu Y, Michler R, Knowles D. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood 1995;85:1396-403.
10. Frizzera G. Atypical lymphoproliferative disorders. In: Knowles D, ed. Neoplastic hematopathology. Baltimore: Williams and Wilkins, 1992:459-96.
11. Goldschmidts W, Bhatia K, Johnson J, et al. Epstein-Barr virus genotypes in AIDS-associated lymphomas are similar to those in endemic Burkitt's lymphomas. Leukemia 1992;6:875-8.
12. Gonzalez C, Medeiros L, Jaffe E. Composite lymphoma: a clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma. Am J Clin Pathol 1991;96:81-9.
13. Hammerschmidt W, Sugden B, Baichwal V. The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J Virol 1989;63:2469-75.
14. Henderson S, Rowe M, Gregory C, et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B-cells from programmed cell death. Cell 1991;65:1107-15.
15. Hu L, Chen F, Zheng F, et al. Clonability and tumorigenicity of human epithelial cells expressing the EBV-encoded membrane protein LMP1. Oncogene 1993;8:1575.
16. Hudson G, Farrell P, Barrell B. Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8. J Virol 1985;53:528-35.
17. Kerr B, Lear A, Rowe M, Croom-Carter D, Young L, Rookes S, Gallimore P, et al. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: Cell phenotype dependence of virus promoter usage. Virology 1992;187:189-201.
18. Kingma D, Medeiros L, Barletta J. Epstein-Barr virus is infrequently identified in non-Hodgkin's lymphomas associated with Hodgkin's disease. Am J Surg Pathol 1994;18:48-61.
19. Knecht H, Bachmann E, Brousset P, et al. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993;82:2937-42.
20. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995;85:552-65.
21. Kumar S, Kumar D, Kingma D, Jaffe E. Epstein-Barr virus-associated T-cell lymphoma in a renal transplant patient. Am J Surg Pathol 1993;17:1046-53.
22. Lee E, Locker J, Nalesnik M, et al. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 1995;332:19-25.
23. Lin J, Lin S, De B, Chan W, Evatt B. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3, and EBER): Predominance of type A virus associated with Hodgkin's disease. Blood 1993;81:3372-81.
24. McClain K, Leach C, Jenson H, et al. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med 1995;332:12-8.
25. Moorthy R, Thorley-Lawson D. All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. J Virol 1993;67:1638-46.
26. Otsuki T, Kumar S, Ensoli B, et al. Detection of human herpes-like DNA sequences in AIDS-associated extranodal lymphoid malignancies. Leukemia 1996;10:1358-62.
27. Rady P, Yen A, Rollefson J, et al. Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet 1995;345:1339-40.
28. Rea D, Delecluse H, Hamilton-Dutoit S, et al. Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas. Ann Oncol 1995;5(Suppl 1):113-6.
29. Sandvej K, Peh S, Andresen B, Pallesen G. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 1994;84(12): 4053-60.
30. Segal GH, Jorgensen T, Masih AS, Braylan RC. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: I. Low grade B-cell lymphoproliferative disorders of non-follicular center cell type. Hum Pathol 1994;25:1269-75.
31. Sullivan J. Epstein-Barr virus and lymphoproliferative disorders. Semin Hematol 1988;25:269-79.
32. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985;43:831-40.
33. Wu T, Mann R, Epstein J, et al. Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. J Virol 1991; 138:1461-9.